These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
61 related articles for article (PubMed ID: 8456320)
1. Treatment of factor VIII inhibitors: products and strategies. Macik BG Semin Thromb Hemost; 1993; 19(1):13-24. PubMed ID: 8456320 [TBL] [Abstract][Full Text] [Related]
2. Application of current knowledge to the management of bleeding events during immune tolerance induction. Di Paola J; Aledort L; Britton H; Carcao M; Grabowski E; Hutter J; Journeycake J; Kempton C; Leissinger C Haemophilia; 2006 Nov; 12(6):591-7. PubMed ID: 17083508 [TBL] [Abstract][Full Text] [Related]
3. Inhibitors of factor VIII: detection and treatment. Brettler DB Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():21-5. PubMed ID: 7886576 [TBL] [Abstract][Full Text] [Related]
4. Treatment of factor VIII inhibitors. Kasper CK Prog Hemost Thromb; 1989; 9():57-86. PubMed ID: 2492380 [No Abstract] [Full Text] [Related]
5. Hemophilia. Strategies for the treatment of inhibitor patients. Ingerslev J Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863 [TBL] [Abstract][Full Text] [Related]
6. Antibodies to factor VIII in hemophilia A patients. Brackmann HH; Schwaab R; Effenberger W; Hess L; Hanfland P; Oldenburg J Vox Sang; 2000; 78 Suppl 2():187-90. PubMed ID: 10938950 [TBL] [Abstract][Full Text] [Related]
7. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy. Field JJ; Fenske TS; Blinder MA Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724 [TBL] [Abstract][Full Text] [Related]
8. Hemophilia factor VIII therapy. Immunological tolerance. A clinical perspective. White GC; Greenwood R; Escobar M; Frelinger JA Haematologica; 2000 Oct; 85(10 Suppl):113-6. PubMed ID: 11187862 [TBL] [Abstract][Full Text] [Related]
9. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors. Reipert BM; van Helden PM; Schwarz HP; Hausl C Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196 [TBL] [Abstract][Full Text] [Related]
10. Hemophilia treatment. Factor VIII inhibitors with recombinant products: prospective clinical trials. Lusher JM Haematologica; 2000 Oct; 85(10 Suppl):2-5; discussion 5-6. PubMed ID: 11187864 [TBL] [Abstract][Full Text] [Related]
11. Inhibitor development in haemophiliacs: theoretical background and clinical aspects. Sultan Y Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S55-7. PubMed ID: 7495970 [TBL] [Abstract][Full Text] [Related]
12. Current treatment of patients with inhibitors to factor VIII. Hilgartner MW Haematologia (Budap); 1986; 19(1):21-32. PubMed ID: 3087840 [TBL] [Abstract][Full Text] [Related]
13. Suggestions for the management of factor VIII inhibitors. Rubinger M; Rivard GE; Teitel J; Walker H; Haemophilia; 2000 Jul; 6 Suppl 1():52-9. PubMed ID: 10982269 [No Abstract] [Full Text] [Related]
14. The role of plasma-derived factor VIII/von Willebrand factor concentrates in the treatment of hemophilia A patients. Auerswald G; Spranger T; Brackmann HH Haematologica; 2003 Jun; 88(6):EREP05. PubMed ID: 12826531 [TBL] [Abstract][Full Text] [Related]
15. Factor VIII inhibitors in patients with hemophilia A: epidemiology of inhibitor development and induction of immune tolerance for factor VIII. Kreuz W; Becker S; Lenz E; Martinez-Saguer I; Escuriola-Ettingshausen C; Funk M; Ehrenforth S; Auerswald G; Kornhuber B Semin Thromb Hemost; 1995; 21(4):382-9. PubMed ID: 8747701 [TBL] [Abstract][Full Text] [Related]
16. Inhibitors to factor VIII:C in nonhemophiliacs. Milica CD; Gradimir JM; Nada S; Radoje CB Am J Hematol; 1996 May; 52(1):61. PubMed ID: 8638615 [No Abstract] [Full Text] [Related]
17. Treatment of two patients with acquired factor VIII inhibitors using cyclophosphamide and prednisone. Hertzberg MS; Favaloro E; Koutts J Am J Hematol; 2002 Aug; 70(4):330-1. PubMed ID: 12210817 [No Abstract] [Full Text] [Related]
18. New protocol for immune tolerance induction in acquired hemophilia. Nemes L; Pitlik E Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874 [TBL] [Abstract][Full Text] [Related]
19. A continuing challenge: treatment of hemophilic children with acquired factor VIII inhibitors. Bell BA Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):105-6. PubMed ID: 8447549 [No Abstract] [Full Text] [Related]